These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22366561)

  • 1. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients.
    Bhoo-Pathy N; Yip CH; Hartman M; Saxena N; Taib NA; Ho GF; Looi LM; Bulgiba AM; van der Graaf Y; Verkooijen HM
    Eur J Cancer; 2012 May; 48(7):982-9. PubMed ID: 22366561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer.
    Wong HS; Subramaniam S; Alias Z; Taib NA; Ho GF; Ng CH; Yip CH; Verkooijen HM; Hartman M; Bhoo-Pathy N
    Medicine (Baltimore); 2015 Feb; 94(8):e593. PubMed ID: 25715267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.
    Jung M; Choi EH; Nam CM; Rha SY; Jeung HC; Lee SH; Yang WI; Roh JK; Chung HC
    Ann Surg Oncol; 2013 Aug; 20(8):2615-24. PubMed ID: 23543197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
    Campbell HE; Taylor MA; Harris AL; Gray AM
    Br J Cancer; 2009 Oct; 101(7):1074-84. PubMed ID: 19724274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
    Yao-Lung K; Dar-Ren C; Tsai-Wang C
    BMC Med Inform Decis Mak; 2012 Sep; 12():108. PubMed ID: 22985190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study.
    de Glas NA; van de Water W; Engelhardt EG; Bastiaannet E; de Craen AJ; Kroep JR; Putter H; Stiggelbout AM; Weijl NI; van de Velde CJ; Portielje JE; Liefers GJ
    Lancet Oncol; 2014 Jun; 15(7):722-9. PubMed ID: 24836274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.
    Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Liepniece-Karele I; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
    Fam Cancer; 2013 Dec; 12(4):683-9. PubMed ID: 23640109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
    Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
    Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after mastectomy with immediate breast reconstruction for breast cancer in a multiethnic, middle-income Asian setting.
    See MH; Sinnadurai S; Lai LL; Tan KL; Teh MS; Teoh LY; Jamaris S; Abdul Malik R; Bhoo-Pathy N
    Surgery; 2021 Dec; 170(6):1604-1609. PubMed ID: 34538341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.
    Hajage D; de Rycke Y; Bollet M; Savignoni A; Caly M; Pierga JY; Horlings HM; Van de Vijver MJ; Vincent-Salomon A; Sigal-Zafrani B; Senechal C; Asselain B; Sastre X; Reyal F
    PLoS One; 2011; 6(11):e27446. PubMed ID: 22087319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of adjuvant chemotherapy on survival of women with T1N0M0, hormone receptor negative breast cancer.
    Bhoo-Pathy NT; Inaida S; Tanaka S; Taib NA; Yip CH; Saad M; Kawakami K; Bhoo-Pathy N
    Cancer Epidemiol; 2017 Jun; 48():56-61. PubMed ID: 28371729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.
    Hearne BJ; Teare MD; Butt M; Donaldson L
    BMJ Open; 2015 Jan; 5(1):e005576. PubMed ID: 25628047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
    Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
    BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of CancerMath.
    Pijnappel EN; Bhoo-Pathy N; Suniza J; See MH; Tan GH; Yip CH; Hartman M; Taib NA; Verkooijen HM
    World J Surg; 2014 Dec; 38(12):3133-7. PubMed ID: 25167896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
    Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
    J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed Opportunities for Loco-Regional Treatment of Elderly Women with Breast Cancer.
    Bhoo-Pathy N; Balakrishnan N; See MH; Taib NA; Yip CH
    World J Surg; 2016 Dec; 40(12):2913-2921. PubMed ID: 27456497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of HER2 amplification in small, node-negative breast cancers: do Asians differ?
    Wong FY; Yip CS; Chua ET
    World J Surg; 2012 Feb; 36(2):287-94. PubMed ID: 22105650
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.